NYSEAMERICAN:SENS Senseonics Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Senseonics Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.38 0.00 (0.00 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range$0.36Now: $0.38▼$0.3850-Day Range N/A52-Week Range$0.36Now: $0.38▼$1.78Volume1.96 million shsAverage Volume2.57 million shsMarket Capitalization$90.99 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesOptions ChainShort InterestSocial Media Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Read More Beat the Market (BTM) Rank™ 3.1 Analyst's Opinion Consensus RatingSenseonics has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 3 buy ratings, 4 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.73, Senseonics has a forecasted upside of 94.6% from its current price of $0.38.Amount of Analyst CoverageSenseonics has only been the subject of 3 research reports in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesSenseonics has received 240 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSenseonics has received 208 “underperform” votes. (Add your “underperform” vote.)Community SentimentSenseonics has received 53.57% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Senseonics and other stocks. Vote “Outperform” if you believe SENS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSenseonics does not currently pay a dividend.Dividend GrowthSenseonics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Senseonics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 34.10% of the stock of Senseonics is held by insiders.Percentage Held by InstitutionsOnly 30.66% of the stock of Senseonics is held by institutions. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.1Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.17 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:SENS Previous SymbolNASDAQ:SENS CUSIPN/A CIKN/A Webwww.senseonics.com Phone+1-301-5157260Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees191 Outstanding Shares241,404,000Market Cap$90.99 million Next Earnings Date11/10/2020 (Estimated) OptionableOptionable $0.38 0.00 (0.00 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive SENS News and Ratings via Email Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter. Senseonics (NYSEAMERICAN:SENS) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Senseonics? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Senseonics. When is Senseonics' next earnings date? Senseonics is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Senseonics. How were Senseonics' earnings last quarter? Senseonics Holdings Inc (NYSEAMERICAN:SENS) released its earnings results on Tuesday, June, 9th. The company reported ($0.21) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $0.09. The business earned $0.03 million during the quarter, compared to analysts' expectations of $0.77 million. View Senseonics' earnings history. What price target have analysts set for SENS? 8 brokers have issued 12-month price targets for Senseonics' shares. Their forecasts range from $0.25 to $1.00. On average, they expect Senseonics' stock price to reach $0.73 in the next year. This suggests a possible upside of 94.6% from the stock's current price. View analysts' price targets for Senseonics. Are investors shorting Senseonics? Senseonics saw a increase in short interest in August. As of August 14th, there was short interest totaling 26,560,000 shares, an increase of 13.5% from the July 30th total of 23,410,000 shares. Based on an average daily trading volume, of 3,320,000 shares, the short-interest ratio is presently 8.0 days. Currently, 18.7% of the shares of the stock are sold short. View Senseonics' Short Interest. Who are some of Senseonics' key competitors? Some companies that are related to Senseonics include Renalytix Ai (RENX), Akumin (AKU), MaxCyte (MXCT), Arch Capital Group (AWH), Yourgene Health (YGEN), Exagen (XGN), Palatin Technologies (PTN), Oncimmune (ONC), Lexagene (LXG), Genedrive (GDR), SQI Diagnostics (SQD), Sernova (SVA), GeneNews (GEN), Cambridge Cognition (COG) and LED Medical Diagnostics (LMD). View all competitors. What other stocks do shareholders of Senseonics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), Advanced Micro Devices (AMD), Micron Technology (MU), Sorrento Therapeutics (SRNE), Tandem Diabetes Care (TNDM), CytoDyn (CYDY), Amarin (AMRN), Nabriva Therapeutics (NBRV), TransEnterix (TRXC) and NVIDIA (NVDA). Who are Senseonics' key executives? Senseonics' management team includes the following people: Dr. Timothy T. Goodnow, Pres, CEO & Director (Age 58, Pay $897.8k)Dr. Mukul Jain, Chief Operating Officer (Age 47, Pay $572.75k)Mr. Nick B. Tressler, Chief Financial Officer (Age 47)Dr. Francine Ratner Kaufman, Chief Medical Officer & Director (Age 69) What is Senseonics' stock symbol? Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS." Who are Senseonics' major shareholders? Senseonics' stock is owned by many different retail and institutional investors. Top institutional investors include NEA Management Company LLC (7.04%), Gilder Gagnon Howe & Co. LLC (6.54%), Charles Schwab Investment Management Inc. (0.28%), Bank of America Corp DE (0.26%), Jane Street Group LLC (0.11%) and Hudson Bay Capital Management LP (0.10%). View institutional ownership trends for Senseonics. Which major investors are selling Senseonics stock? SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Gilder Gagnon Howe & Co. LLC, Bank of New York Mellon Corp, Charles Schwab Investment Management Inc., and Hudson Bay Capital Management LP. View insider buying and selling activity for Senseonics. Which major investors are buying Senseonics stock? SENS stock was acquired by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Jane Street Group LLC, Virtu Financial LLC, and Golden State Wealth Management LLC. View insider buying and selling activity for Senseonics. How do I buy shares of Senseonics? Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Senseonics' stock price today? One share of SENS stock can currently be purchased for approximately $0.38. How big of a company is Senseonics? Senseonics has a market capitalization of $90.99 million. Senseonics employs 191 workers across the globe. What is Senseonics' official website? The official website for Senseonics is www.senseonics.com. How can I contact Senseonics? Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
